Fundz

Protembis GmbH raised €30 million in a Series B funding round co-led by a European consortium of VC investors to support the enrollment of the PROTEMBO Investigational Device Exemption (IDE) Pivotal Trial.

PRIVATEMar 26, 2024

Amount Raised

€30 Million

Round Type

Series B

AachenBiotechnologyHealth CareMedicalMedical Device

Investors

CoparionTech Vision FundXGEN VentureSegulah Medical Acceleration

Description

Protembis GmbH completed a €30 million Series B financing round to support the enrollment of the PROTEMBO Investigational Device Exemption (IDE) Pivotal Trial (NCT05873816). The funding round was co-led by a European consortium of VC investors including Sweden-based Segulah Medical Acceleration, Italy-based XGEN Venture, and Germany-based TechVision Fund. Other investors include Coparion, several large family offices, angel investors, and a multinational medical device strategic.

Quick answer

Protembis GmbH raised €30 Million in a Series B round, dated March 26, 2024. Investors: Coparion, Tech Vision Fund, XGEN Venture and Segulah Medical Acceleration. Protembis GmbH is based in Aachen, North Rhine Westphalia, Germany.

How much did Protembis GmbH raise?
Protembis GmbH raised €30 Million in a Series B round on March 26, 2024.
Who invested in Protembis GmbH?
Coparion, Tech Vision Fund, XGEN Venture and Segulah Medical Acceleration are named as investors in this round.
What does Protembis GmbH do?
Protembis GmbH is a privately held emerging medical device company that has developed the ProtEmbo® Cerebral Protection System.
Where is Protembis GmbH based and how big is it?
Protembis GmbH is based in Aachen, North Rhine Westphalia, Germany.
Who are the decision-makers at Protembis GmbH?
Fundz holds 1 contact at Protembis GmbH. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as Protembis GmbH that raised within 45 days of this round, from Fundz verified event records.

  • Nami Surgical raised $4M (Seed) on May 8, 2024.
  • Inheart raised $11M (Funding Round) on May 7, 2024.
  • neuroClues raised $5.4M (Pre-Series A) on April 30, 2024.
  • AtaCor Medical raised $28M (Series C) on April 24, 2024.
  • Flyte raised $5M (Seed) on April 22, 2024.
  • Nami Surgical raised $123K (Pre-Seed) on April 22, 2024.

Who to call at Protembis GmbH, and when

A new round usually means Protembis GmbH is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Protembis GmbH raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Protembis GmbH, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Protembis GmbH. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Protembis GmbH

Location

Aachen, North Rhine Westphalia, Germany

About

Protembis GmbH is a privately held emerging medical device company that has developed the ProtEmbo® Cerebral Protection System. The company strives to provide a simple and reliable solution to protect patients from brain injury during left-sided heart procedures, improving patient quality of life and reducing overall healthcare costs associated with brain injury during such procedures.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Protembis GmbH raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Protembis GmbH's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Protembis GmbH raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.